Henry Schein (HSIC) vs RadNet (RDNT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Henry Schein (HSIC) has outperformed RadNet (RDNT) over the past year, gaining 28.9% versus a loss of 11.9%. Over five years, RDNT leads with a +138.4% price change compared with +8.0% for HSIC. Henry Schein is the larger company by market cap ($9.32 billion vs $5.40 billion), about 1.7 times the size, while RadNet is growing revenue faster (+11.5% vs +4.0%).
On valuation, Henry Schein trades at a lower forward P/E (14.0x vs 77.4x for RadNet). Henry Schein converts more of its revenue into profit, with a net margin of 3.0% versus -0.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HSIC | RDNT |
|---|---|---|
| Share price | $83.66 | $68.61 |
| Market cap | $9.32B | $5.40B |
| 1-day change | -1.39% | -2.38% |
| YTD return | +10.69% | -3.84% |
| 1-year return | +28.95% | -11.94% |
| 5-year return | +8.03% | +138.39% |
| P/E ratio (TTM) | 24.39 | — |
| Forward P/E | 13.98 | 77.38 |
| EPS (TTM) | $3.43 | $-0.27 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $13.18B | $2.04B |
| Revenue growth (YoY) | +4.03% | +11.51% |
| Net income (latest FY) | $398.00M | $-18.65M |
| Gross margin | 31.14% | — |
| Operating margin | 4.95% | 3.04% |
| Net margin | 3.02% | -0.91% |
| 52-week high | $92.18 | $85.84 |
| 52-week low | $61.95 | $50.82 |
| Distance from 52-week high | -9.24% | -20.07% |
| Analyst consensus | buy | none |
| Avg. price target upside | +16.27% | +37.92% |
| Average volume | 1.19M | 716.37K |
| Shares outstanding | 111.45M | 78.70M |
| Employees | 25,000 | 11,000 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HSIC has outperformed RDNT by 40.9 percentage points over the past year.
- RadNet grew revenue faster in its latest fiscal year (+11.51% vs +4.03%).
About Henry Schein
HSIC stock →Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide.
Health Care · Medical Specialities · 25,000 employees
About RadNet
RDNT stock →RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health.
Health Care · Medical Specialities · 11,000 employees
HSIC vs RDNT FAQ
Which is bigger, Henry Schein or RadNet?
Henry Schein (HSIC) is larger, with a market capitalization of $9.32B compared with $5.40B for RadNet (RDNT).
Which stock has performed better over the past year, HSIC or RDNT?
HSIC returned +28.95% over the past 12 months, compared with -11.94% for RDNT (price return, excluding dividends). Past performance does not predict future results.
Are Henry Schein and RadNet in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.